Objective-Earlier in vitro studies suggested a putative role for the plasma phospholipid transfer protein (PLTP) in the modulation of blood coagulation. The effect of PLTP expression on blood coagulation under both basal and oxidative stress conditions was compared here in wild-type and PLTP-deficient (PLTPϪ/Ϫ) mice. Methods and Results-Under basal conditions, PLTP deficiency was associated with an extended tail bleeding time despite a significant depletion of vascular ␣-tocopherol content and an impairment of endothelial function. When acute oxidative stress was generated in vivo in the brain vasculature, the steady state levels of oxidized lipid derivatives, the extent of blood vessel occlusion, and the volume of ischemic lesions were more severe in wild-type than in PLTPϪ/Ϫ mice. Conclusion-In addition to its recognized hyperlipidemic, proinflammatory, and proatherogenic properties, PLTP increases blood coagulation and worsens the extent of ischemic lesions in response to acute oxidative stress. Thus, PLTP arises here as a cardiovascular risk factor for the late thrombotic events occurring in the acute phase of atherosclerosis. (Arterioscler Thromb Vasc Biol. 2010;30:2452-2457.)
P lasma phospholipid transfer protein (PLTP) binds and transfers a number of amphipathic compounds, including phospholipids, unesterified cholesterol, diacylglycerides, lipopolysaccharides, and vitamin E. It has been implicated in several biological processes, including the production and catabolism of very-low-density and low-density lipoproteins and the remodeling of high-density lipoproteins. Overall, PLTP expression was found to result in a higher incidence and faster progression of atherosclerosis in animal models, and increased expression of PLTP was most frequently associated with an increased risk of cardiovascular disease in humans. 1, 2 These observations recently led to the emergence of pharmacological PLTP inhibitors as putative therapeutic tools in the prevention and treatment of cardiovascular disease. 3 Because of its hyperlipidemic and proinflammatory properties, PLTP increases the formation of fatty streaks and atherosclerotic lesions in the early, silent phase of the disease. In this context, the proatherogenicity of PLTP was mainly explained in terms of an increased production and reduced antioxidative protection of plasma apolipoprotein B-containing lipoproteins. 4 -6 In contrast, the implication of PLTP in the distal, thrombotic events of the disease (in particular the interaction between the hypercoagulable blood and the vascular wall) has not yet been studied in vivo. Addressing the latter point is warranted by recent but contradictory sets of data that were obtained in vitro. On the one hand, PLTP was described as a putative factor in hypocoagulation because it has the ability in vitro (1) to favor the scavenging of anionic phospholipids (mainly phosphatidylserine [PS]), thus resulting in the attenuation of their procoagulant effect, 7 and (2) to prevent endothelium dysfunction, possibly through the exchange of vitamin E between lipoproteins and cells. 5, 6, 8 In contrast, PLTP has also been shown to have hypercoagulant properties through its ability to produce vitamin E-poor erythrocytes, which were shown in vitro to display more externalized PS in the outer membrane leaflet and increased procoagulant activity. 9 In the present in vivo studies, both basal and stimulated blood coagulation were compared in wild-type (WT) and PLTP-deficient mice. Under basal conditions, PLTP deficiency was associated with an extended tail bleeding time, despite concomitant reductions in both the ␣-tocopherol content of the vascular wall and the endotheli-um-dependent vascular relaxation. By using an in vivo integrative approach through the focal generation of acute oxidative stress within the brain vasculature, we observed that the sequestration of ␣-tocopherol in blood from PLTPdeficient mice was associated with a slowdown of the coagulation process and a significant reduction in ischemic tissue damage.
Methods
PLTP-knockout homozygous (PLTPϪ/Ϫ) and WT mice from a homogeneous C57BL/6 background were fed a standard chow diet, and they had free access to water and food (A03 diet, Safe). All of the experiments involving animals were approved by the Ethical Committee on the Use of Laboratory Animals of the University of Burgundy (protocol number 1305), and they were performed in accordance with institutional guidelines.
Results are expressed as meanϮSEM. The statistical significance of differences between data means was determined using the nonparametric Mann-Whitney U test or the Student t test, as appropriate.
Supplemental Materials and Methods (animals, bleeding time, determination of vascular reactivity, platelet preparation, platelet function, photothrombosis and infarct measurement, immunohistochemistry, cytokine and chemokine measurements, ␣-tocopherol assay, cholesterol/linoleic acid [LA]/hydroxyoctadecadienoic acid [HODE] assays, and protein assay) are available online at http://atvb.ahajournals.org.
Results

PLTP Deficiency and Blood Coagulation
In a first attempt to assess the effect of PLTP expression level on blood coagulation in vivo, tail bleeding time in PLTPknockout homozygous (PLTPϪ/Ϫ) mice was compared with that in WT mice. As shown in Figure 1 , a significant increase in tail bleeding time was observed in PLTPϪ/Ϫ mice compared with WT mice. Cessation of bleeding was observed on average after 83.8Ϯ10.0 seconds in WT versus 121.3Ϯ13.9 seconds in PLTPϪ/Ϫ mice (PϽ0.05). When platelet aggregation was selectively assessed in fresh whole blood using the platelet function analyzer-100 closure time test, no significant difference was observed between WT and PLTPϪ/Ϫ mice (mean closure time, 80.8Ϯ4.3 versus 96.9Ϯ9.3 seconds in WT [nϭ9] and PLTPϪ/Ϫ [nϭ9] mice, respectively; not significant). With regard to endothelium function, ie, a known determinant of vascular occlusion, endothelium-dependent contractions induced by N-nitro-L-arginine (10 mol/L) (measure of basal endothelial NO production) were similar in control and PLTPϪ/Ϫ mice (747Ϯ75 versus 884Ϯ69 mg, respectively; not significant), indicating that production of nitric oxide in the aorta was similar in WT and PLTPϪ/Ϫ mice under basal conditions. We then searched for the consequences of PLTP deficiency on the vasoactive response of thoracic aorta segments to the potent vasoconstrictor norepinephrine (NE). The aortic segments of adult mice showed similar responses to NE whether the mice expressed PLTP or not, with no differences in both E max and pD 2 values between the 2 genotypes ( Figure 2B ). Finally, the relaxing response curve of NE-precontracted aorta to cumulated concentrations of acetylcholine (ACh) was shifted to the right, with a significantly lower degree of endothelium-dependent relaxation induced by the 3 nmol/L to 10 mol/L ACh doses ([ACh] log M: Ϫ8.5 to Ϫ5, respectively) in PLTPϪ/Ϫ mice as compared with WT mice (PϽ0.01 in all cases) ( Figure 2A ). Mean pD 2 values were significantly lower in PLTPϪ/Ϫ mice than in WT mice (Pϭ0.004), reflecting a significantly weaker sensitivity to ACh of the aorta from PLTPϪ/Ϫ animals ( Figure 2B ). PLTP deficiency was also associated with a significant 17% reduction in maximal ACh-induced relaxation of precontracted aorta (E max ) ( Figure 2B ). Taken together, these observations indicate that PLTP deficiency is associated with a weaker hemostatic function in nonstimulated mice, which can be explained neither by defective platelet aggregation nor by improved endothelial function. Subsequently, intravascular thrombosis was induced in the brain through the transillumination of systemically injected Rose Bengal by filtered light. 10, 11 Twenty-four hours after photothrombotic stroke induction, the mice were euthanized, and living versus dead cells were localized on Cresyl violet-stained sections. PLTPϪ/Ϫ mice showed significantly smaller lesion volumes compared with WT mice (infarct volume, 5.90Ϯ0.61 mm 3 in nϭ11 PLTPϪ/Ϫ versus 9.65Ϯ1.09 mm 3 in nϭ16 WT mice, PϽ0.05) ( Figure 3A ). When the brains of WT and PLTPϪ/Ϫ mice were harvested only 2 hours after the induction of photothrombosis, cut on a cryostat, and immunostained for the presence of fibrin, the volume of fibrin-positive tissue in PLTPϪ/Ϫ mice was 52% lower than that in WT mice (fibrin-positive tissue, 2.91Ϯ0.59 versus 6.10Ϯ0.93 mm 3 in PLTPϪ/Ϫ and WT mice, respectively; PϽ0.05) ( Figure 3B ). In contrast, ischemia-induced edema, measured as the ratio between the volumes of ipsilateral and contralateral hemispheres 24 hours postischemia was similar in both groups (meanϮSEM, 1.060Ϯ0.015 versus 1.047Ϯ0.012 in WT and PLTPϪ/Ϫ mice, respectively; Pϭ0.41), and terminal deoxynucleotidyl transferase dUTP nick-end labeling staining showed no difference in the density of apoptotic cells in WT compared with PLTPϪ/Ϫ lesions (not shown). Finally, interleukin-6 and monocyte chemoattractant protein 1 levels were increased in plasma and in infarcted brain 24 hours postischemia, with similar observations in WT and PLTPϪ/Ϫ mice (not shown).
Overall, these data indicate that the extent of occlusion of blood vessels is greater in WT than in PLTPϪ/Ϫ mice after intravascular oxidative stimulation of thrombosis. Hypercoagulable blood accounts for differences in infarct volumes between WT and PLTPϪ/Ϫ animals, with no evidence that supports contributions of the intrinsic responsiveness of the brain tissue or of endothelium function to the observed phenotype.
PLTP Deficiency Is Accompanied by Imbalanced Vitamin E Distribution Between Circulating Elements and the Vascular Wall
In accordance with previous findings, 5 the level of vitamin E was decreased in aortas of PLTPϪ/Ϫ mice compared with WT mice (␣-tocopherol to artery weight ratios, 4.8Ϯ0.5 versus 7.1Ϯ0.9 ng/mg of tissue in PLTPϪ/Ϫ and WT mice, respectively; PϽ0.05). In addition, and in accordance with previous findings, 12 we observed a significant decrease in brain ␣-tocopherol content in PLTPϪ/Ϫ compared with WT mice, with consistent observations whether expressed as the ratio of ␣-tocopherol to cholesterol or of ␣-tocopherol to LA ( Figure 4A ). In contrast, red blood cells from PLTPϪ/Ϫ mice were significantly enriched with ␣-tocopherol compared with those of WT mice, again with consistent observations whether expressed as ␣-tocopherol to cholesterol or as ␣-tocopherol to LA ratio ( Figure 4B ). Plasma ␣-tocopherol to cholesterol ratio was higher in PLTPϪ/Ϫ than in WT mice, with no difference when expressed as ␣-tocopherol to LA ratio ( Figure 4C ). The latter point might relate to the fact that ␣-tocopherol is a significant determinant of antioxidant protection in the plasma compartment. Thus, a better preservation of LA would be ensured when ␣-tocopherol is high, resulting in a constant ratio. This may be less prominent in cells and tissues, where other antioxidants probably act besides ␣-tocopherol. Finally, the count and the ␣-tocopherol content of platelets did not differ between WT and PLTPϪ/Ϫ mice (382.3Ϯ31.6 versus 319.4Ϯ24.5 10 6 cells/mL and 164Ϯ 18 versus 173Ϯ27 ng/mg protein, respectively; not significant in both cases). These observations are consistent with a role of PLTP in redistributing ␣-tocopherol from the intravascular compartment toward tissues.
Intravascular Production of HODE Is Restrained in PLTP؊/؊ Mice
To assess oxidative stress, total HODE was measured in ischemic (right) and nonischemic (left) brain hemispheres of WT and PLTPϪ/Ϫ mice ( Figure 5A ), as well as in total blood ( Figure 5B ) 2 hours after initiation of photothrombosis. As shown in Figure 5A , the HODE level was significantly higher Figure 3 . Effect of PLTP deficiency on photothrombosisinduced cerebral infarction. A, Anesthetized mice (nϭ16 WT and nϭ13 PLTPϪ/Ϫ) were infused intravenously with Rose Bengal, and a 532-nm laser beam was focused through the skull on the right hemisphere. Mice were euthanized 24 hours after the onset of ischemia, and injured cortical areas (see arrows on the 2 representative stained brain sections) were measured on coronal sections after staining with Cresyl Violet. The distances between respective coronal sections were used to calculate a linear integration for the lesion volume. *PϽ0.02 versus WT (Student t test). B, Fluorescent immunostaining was performed on coronal brain sections of WT (nϭ9) and PLTPϪ/Ϫ (nϭ6) mice euthanized 2 hours after ischemia using anti-human fibrinogen/fibrin antibodies. Fibrin-positive areas (see the 2 representative antifibrin brain sections) were measured by computerized analysis, and the distances between respective coronal sections were used to calculate a linear integration for the volume of fibrinpositive tissue. Nonspecific brain sections correspond to negative controls and were obtained with nonimmune rabbit IgG instead of the primary anti-fibrin antibodies. *PϽ0.05 versus WT (Mann-Whitney U test).
in nonischemic brain tissue of PLTPϪ/Ϫ mice than in that of WT mice. In the infarcted zone of the brain, a significant increase in HODE level was observed in WT mice but not PLTPϪ/Ϫ mice, leading in the end to comparable HODE levels in both groups. Similar trends were observed whether HODE levels were expressed as the ratio of HODE to cholesterol or HODE to LA. This suggests that in this experimental setting, brain vitamin E (which was more abundant in WT mice; see above) did not confer protection against intravascular oxidative injury. As far as the intravascular compartment is concerned, elevated amounts of HODE were measured in both genotypes 2 hours after induction of the photochemical reaction between Rose Bengal and filtered light, with significantly greater amounts of HODE generated in blood of WT than in blood of PLTPϪ/Ϫ mice ( Figure 5B ). Although amplification of oxidation during blood sampling and treatment cannot be fully excluded, it remains that significant differences were observed between the 2 genotypes. Thus, these data indicate that PLTP deficiency is associated with a better resistance to intravascular oxidative stress.
Discussion
Beyond the ability of plasma phospholipid transfer protein (PLTP) to promote and accelerate the formation of arterial lesions in the earlier steps of atherogenesis, 1,4,6 it is shown here for the first time that PLTP can contribute to the modulation of blood coagulation and as a result may influence the late, thromboembolic phase of the disease. Photoinduction of intravascular oxidative stress, like that occurring in the acute phase of atherothrombosis, was found to be less severe in PLTPϪ/Ϫ than in WT mice. In PLTPϪ/Ϫ mice, the accumulation of vitamin E in circulating elements was associated with an extended bleeding time, a greater resistance to oxidative stress, a reduction in clot formation in the brain microvasculature, and a lesser extent of ischemic lesions. This reduction of intravascular thrombosis in PLTPϪ/Ϫ mice occurred in spite of a significant impairment of endothelium function.
Over the past decade, and in addition to the liver ␣-tocopherol transfer protein (␣-TTP), 13, 14 PLTP has emerged as an important determinant of vitamin E metabolism. Although ␣-TTP plays a key role in mediating the secretion of liver vitamin E into the bloodstream, PLTP has the ability to control the balance of vitamin E between intravascular circulating elements and tissues. 5, 6, 8, 9, 12 The PLTP-mediated transfer of vitamin E from circulating elements toward the vascular wall has 2 concomitant but opposite effects in terms of vascular biology. On the one hand, PLTP was shown to contribute to the preservation of a normal endothelium function in ex vivo experiments on isolated arterial rings, possibly reflecting its ability to incorporate vitamin E in the vascular wall. 8 On the other hand, the PLTP-mediated leakage of vitamin E out of the intravascular compartment produces vitamin E-poor lipoproteins and circulating cells, with 2 detrimental consequences: first, a weaker resistance to . ␣-Tocopherol distribution in brain, red blood cells, and plasma of WT and PLTPϪ/Ϫ mice. ␣-Tocopherol (␣-toco) was extracted from brain, red blood cells, and plasma of WT and PLTPϪ/Ϫ mice and quantitated by high-performance liquid chromatography. Results are expressed as ␣-tocopherol to cholesterol ratio (left panels) and as ␣-tocopherol to LA ratio (right panels). Data are meanϮSEM of nϭ4 WT and nϭ4 PLTPϪ/Ϫ for brain measurements, nϭ9 WT and nϭ10 PLTPϪ/Ϫ for red blood cell measurements, and nϭ9 WT and nϭ10 PLTPϪ/Ϫ mice for plasma measurements. *PϽ0.05, **PϽ0.0001 versus WT (Mann-Whitney U test). Figure 5 . HODE levels in brain and blood of WT and PLTPϪ/Ϫ mice. HODE levels were measured in brain and blood samples of WT (nϭ7; filled bars) and PLTPϪ/Ϫ (nϭ9; open bars) mice by liquid chromatography-tandem mass spectrometry, as described in Materials and Methods. A, HODE levels in ischemic (right) and nonischemic (left) brain 2 hours after photothrombosis. a, PϽ0.005 versus WT; b, PϽ0.05 versus homologous left hemisphere (Mann-Whitney U test) B, HODE levels in total blood before (tϭ0) and after (tϭ2 hours) photothrombotic ischemia. c, PϽ0.02; d, PϽ0.002 versus homologous tϭ0 samples; e, PϽ0.01 versus WT tϭ2 hours (Mann-Whitney U test). intravascular oxidative transformations, 5, 6 and second, a higher propensity to externalize the prothrombotic PS in the outer leaflet of the erythrocyte membranes where ␣-tocopherol normally localizes. 9, 15 However, the putative procoagulant effect of the PLTP-mediated redistribution of intravascular vitamin E was challenged by recent in vitro observations, which reported that PLTP can inactivate the anionic phospholipids in erythrocytes through their transfer from artificial liposomes toward plasma lipoproteins. 7 In the context of these contrasting observations, complementary studies in animal models were needed to work out whether PLTP activity actually exerts pro-or anticoagulant properties in vivo.
In an attempt to determine the impact of PLTP and vitamin E on endothelium function, ie, a known determinant of the thrombotic risk, vasomotor tone was investigated in the present study on aortic rings from WT and PLTPϪ/Ϫ mice. We observed that reduced basal vitamin E content of the vascular wall occurs in PLTP-deficient mice and is associated with impaired ability of the endothelium to vasorelax in response to ACh under standard conditions. These findings are in line with previous observations, 16 which showed that enrichment of the vascular tissue with ␣-tocopherol, possibly by way of the PLTP-mediated transfer reaction, 8 has the ability to preserve normal endothelium function through the inhibition of protein kinase C stimulation.
To determine whether PLTP activity amplifies or attenuates blood coagulation, we turned to in vivo studies. Under basal/unstimulated conditions, tail bleeding time in PLTPϪ/Ϫ mice was longer than that in WT mice. This is consistent with earlier in vitro observations of extended clotting time of whole blood drawn from PLTP-deficient mice compared with whole blood drawn from WT mice. 9 In the present study, assessment of platelet function allowed to exclude that impaired hemostatic function in PLTPϪ/Ϫ mice is related to defective platelet aggregation. At baseline, this effect was previously explained in terms of a nonantioxidant property of ␣-tocopherol, which is able to modify the organization and fluidity of cell membrane and to reduce PS externalization in PLTPϪ/Ϫ erythrocytes in the absence of changes in oxidation status. 9 The brain is a highly vascularized organ, and under stimulated oxidative stress conditions the volume of the infarcted tissue is a reliable measure of the extent of thrombosis in the vascular network. 17 Thus, homozygous PLTPϪ/Ϫ mice (with no detectable PLTP activity - 18 ) and WT mice (with naturally high plasma PLTP activity 19 ) were next compared in a mouse model of focal cerebral photothrombosis, ie, in situ laser-mediated generation of a high oxidative stress leading to the thrombotic occlusion of brain microvasculature. The extent of in situ infarcted tissue was found to be clearly reduced in PLTPϪ/Ϫ mice as compared with WT mice. In further support of a reduced thrombotic response associated with the PLTP-deficient state, the mean volume of fibrin-positive tissue measured 2 hours after photothrombosis in PLTPϪ/Ϫ mice was markedly lower than that measured in WT mice. Inhibition of thrombus formation was concomitant with decreases in the vitamin E content of the aortic wall and the brain, but with a marked accumulation of vitamin E in circulating elements 9 (present study). The accumulation of vitamin E in circulating elements from PLTPϪ/Ϫ animals probably accounts for the significant decrease in oxidation-induced blood coagulation. Indeed, earlier human and animal studies reported strong negative relationships between oxidative stress and the vitamin E content of red blood cells. 20 -22 Alternatively, changes in lipid composition (including unsaturation and length of acyl chains as reported earlier in PLTP-knockout mice 23 ) might also contribute to differences in lipid peroxidation. Finally, PLTP-mediated direct neutralization of the procoagulant PS, 7 as well as PLTP-dependent upregulation of endothelium activation 8 (present study), could be excluded in this setting because they would have led to a decrease rather than an increase in tissue injury.
␣-Tocopherol, the main isomer of vitamin E, is mostly recognized as a potent antioxidant with pleiotropic effects. 24, 25 Although epidemiological and animal studies indicated a potential beneficial impact of vitamin E against cardiovascular disease and its complications, studies of vitamin E supplementation in humans have brought conflicting results. 26 -28 In fact, beyond total vitamin E content of the whole body, tissue levels (ie, amounts of ␣-tocopherol in biomembranes) would be more meaningful than plasma levels, and the relative distribution between blood and tissues may well determine the extent of the expected beneficial outcome. 29, 30 In fact, the conclusions of most human studies were built on measurements of vitamin E concentration in plasma only, and this limitation might actually account for some of the heterogeneous observations. Interestingly, arterial injury of the common carotid artery in humans was found to be negatively associated with the vitamin E content of red blood cells, but not of plasma. 31, 32 In addition, total plasma vitamin E concentration was shown to be a poor predictor of cell vitamin E status. 22, 33 Finally, reduced vitamin E content of circulating red blood cells and lipoproteins was thought to result from faster delivery to extravascular tissues rather than from impairment of their replenishment. 5, 34 The present study emphasizes the validity of assessing the compartmental distribution of vitamin E in vivo. It demonstrates that the localization of vitamin E in circulating elements versus tissues relies to a great extent on the level of plasma PLTP activity, which might play a key role in accelerating the transfer of vitamin E out of the intravascular compartment.
In conclusion, PLTP has a dual role in vascular homeostasis. On the one hand, it increases the vitamin E content of the vascular wall, thus preserving endothelium function under basal conditions. On the other hand, it reduces the vitamin E content of circulating elements, thus decreasing the ability of the intravascular compartment to cope with elevated oxidative stress and increasing blood coagulation. Interestingly, high-risk patients with obesity or type 2 diabetes are known to cumulate high plasma PLTP, 35 low vitamin E content of red blood cells 36, 37 and lipoproteins, 38 and high lipid peroxidation in erythrocyte membranes. 39, 40 The present study suggests that the PLTP-mediated leakage of ␣-tocopherol out of the blood compartment may make a major contribution to increased thrombotic risk in these patients.
